ReposiTrak
TRAK · NYSE
About TRAK
- Employees
- 69
- Headquarters
- Murray, Utah
- Listed
- Nov 18, 1998
- Sector
- Information Technology
- Industry
- Software
- Website
- repositrak.com
TRAK key statistics
- Market cap
- 131.05M
- Price-earnings ratio
- 18.46
- Dividend yield
- 1.25%
- Average volume
- 76.04K
- Volume
- 79.18K
- Open price
- $7.25
- High today
- $7.41
- Low today
- $7.23
- 52 Week high
- $15.80
- 52 Week low
- $6.94
ReposiTrak (TRAK) at a glance
As of Oct 20, 2026, ReposiTrak (TRAK) shares are priced at $7.26, giving the company a market cap of 131.05M, a price-to-earnings ratio of 18.46 and a dividend yield of 1.25%.
Today the stock has traded between $7.23 and $7.41. The current price is 0.4% above the day's low and 2.0% below its high.
Volume so far is 79.18K shares, in line with the average of 76.04K shares a day.
Over the past year ReposiTrak has ranged from $6.94 to $15.80, and now sits 4% of the way up that range.
ReposiTrak met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q4 FY26 it reported $0.11 per share against an estimate of $0.0918.
TRAK earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 12.6% on average.
- Q1 FY25: reported $0.08 per share against an estimate of $0.0816
- Q2 FY25: reported $0.08 per share against an estimate of $0.0918
- Q3 FY25: reported $0.10 per share against an estimate of $0.0918
- Q4 FY25: reported $0.08 per share against an estimate of $0.0918
- Q1 FY26: reported $0.09 per share against an estimate of $0.102
- Q2 FY26: reported $0.09 per share against an estimate of $0.0918
- Q3 FY26: reported $0.10 per share against an estimate of $0.0918
- Q4 FY26: reported $0.11 per share against an estimate of $0.0918
TRAK news
- Press releaseBusiness Wire
- Press releaseBusiness Wire
ReposiTrak Touchless Retail™ Leads to 6% Sales Increase for National Dairy
- Press releaseBusiness Wire
ReposiTrak Reports 16% Increase in Net Income 20% Increase in EPS, for Fourth Quarter of Fiscal 2026
- Press releaseBusiness Wire
ReposiTrak, Inc. Declares Quarterly Cash Dividend
- Press releaseBusiness Wire
ReposiTrak’s Touchless Retail™ Begins Deployment for Leading Paper Goods Supplier with Large Eastern Retailer
- Press releaseBusiness Wire
ReposiTrak Schedules Full-Year Fiscal 2026 Earnings Conference Call and Webcast for September 28, 2026
- Press releaseBusiness Wire
ReposiTrak and SPAR Launch Touchless Retail™: Professional Merchandising at Half the Traditional Cost
- Press releaseBusiness Wire
Associated Grocers Northeast Selects ReposiTrak to Launch Enterprise Traceability Program
Similar companies
Companies in the same industry as ReposiTrak
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.